Original Article
Computer-aided diagnostic system with automated deep learning method based on the AutoGluon framework improved the diagnostic accuracy of early esophageal cancer
Journal of Gastrointestinal Oncology
2024;
15
(2)
:535-543
.
(30 April 2024)
Totally minimally invasive laparoscopic robot-assisted Ivor Lewis esophagectomy: improved technique and outcomes over 200 cases
Journal of Gastrointestinal Oncology
2024;
15
(2)
:544-554
.
(30 April 2024)
Effect of perioperative blood transfusion on complications and prognosis after radical gastrectomy in elderly patients: a retrospective study of 1,666 cases
Journal of Gastrointestinal Oncology
2024;
15
(2)
:555-565
.
(30 April 2024)
Clinical outcome of non-curative endoscopic submucosal dissection for early gastric cancer
Journal of Gastrointestinal Oncology
2024;
15
(2)
:566-576
.
(30 April 2024)
Contribution of genetic polymorphism in ABCB1 to individual variations of imatinib plasma levels in patients with gastrointestinal stromal tumor
Journal of Gastrointestinal Oncology
2024;
15
(2)
:577-584
.
(30 April 2024)
Immune checkpoint inhibitors combined with paclitaxel-based chemotherapy versus chemotherapy alone as first-line treatment in HER2-negative advanced gastric cancer: result of a multicenter retrospective study
Journal of Gastrointestinal Oncology
2024;
15
(2)
:585-596
.
(30 April 2024)
The exploration of surgery and survival prediction in patients with peritoneal metastasis from gastric adenocarcinoma based on the SEER database
Journal of Gastrointestinal Oncology
2024;
15
(2)
:597-611
.
(30 April 2024)
Efficacy and safety of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil monotherapy for refractory metastatic colorectal cancer: a retrospective cohort study
Journal of Gastrointestinal Oncology
2024;
15
(2)
:612-629
.
(30 April 2024)
Efficacy and safety of gemcitabine plus raltitrexed or S-1 versus standard third-line therapies in metastatic colorectal cancer: a retrospective cohort study
Journal of Gastrointestinal Oncology
2024;
15
(2)
:630-640
.
(30 April 2024)
High expression of NXPH4 correlates with poor prognosis, metabolic reprogramming, and immune infiltration in colon adenocarcinoma
Journal of Gastrointestinal Oncology
2024;
15
(2)
:641-667
.
(30 April 2024)
Construction and validation of a nomogram for predicting disease-free survival after radical resection of rectal cancer using perioperative inflammatory indicators
Journal of Gastrointestinal Oncology
2024;
15
(2)
:668-680
.
(30 April 2024)
Survival in metastatic microsatellite-stable colorectal cancer correlated with tumor mutation burden and mutations identified by next-generation sequencing
Journal of Gastrointestinal Oncology
2024;
15
(2)
:681-688
.
(30 April 2024)
Assessing the effectiveness and safety of surufatinib versus everolimus or sunitinib in advanced neuroendocrine neoplasms: insights from a real-world, retrospective cohort study using propensity score and inverse probability treatment weighting analysis
Journal of Gastrointestinal Oncology
2024;
15
(2)
:689-709
.
(30 April 2024)
Efficacy and safety analysis of selective hepatic vein occlusion combined with arterial chemoembolization versus conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2024;
15
(2)
:710-720
.
(30 April 2024)
Hepatic arterial infusion chemotherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: exploring the influence of prior transarterial chemoembolization and additional transarterial chemoembolization on survival outcomes
Journal of Gastrointestinal Oncology
2024;
15
(2)
:721-729
.
(30 April 2024)
Solute carrier family 16 member 1 as a potential prognostic factor for pancreatic ductal adenocarcinoma and its influence on tumor immunity
Journal of Gastrointestinal Oncology
2024;
15
(2)
:730-746
.
(30 April 2024)
Multiple primary tumors in patients with surgically treated pancreatic cancer: a SEER population-based study
Journal of Gastrointestinal Oncology
2024;
15
(2)
:747-754
.
(30 April 2024)
Metabolomics for early pancreatic cancer detection in plasma samples from a Swedish prospective population-based biobank
Journal of Gastrointestinal Oncology
2024;
15
(2)
:755-767
.
(30 April 2024)
PD-L1 expression in pancreaticobiliary adenosquamous carcinoma: a single-institution case series
Journal of Gastrointestinal Oncology
2024;
15
(2)
:768-779
.
(30 April 2024)
Case Series
Regorafenib for patients with progression of advanced hepatocellular carcinoma after treatment with atezolizumab plus bevacizumab: a case series
Journal of Gastrointestinal Oncology
2024;
15
(2)
:780-787
.
(30 April 2024)
Case Report
Treatment of BRAF V600E mutant gastrointestinal stromal tumor with dabrafenib: a case report
Journal of Gastrointestinal Oncology
2024;
15
(2)
:788-793
.
(30 April 2024)
Transarterial chemoembolization for omental vein tumor thrombosis in hepatocellular carcinoma: a case report
Journal of Gastrointestinal Oncology
2024;
15
(2)
:794-799
.
(30 April 2024)
Editorial Commentary
The emerging role of intra-tumoral bacteria
Journal of Gastrointestinal Oncology
2024;
15
(2)
:800-802
.
(30 April 2024)
Letter to the Editor
A description of the correction of data error and the direction of in-depth research
Journal of Gastrointestinal Oncology
2024;
15
(2)
:803-804
.
(30 April 2024)
Is brachial artery approach safe for hepatic artery infusion chemotherapy?
Journal of Gastrointestinal Oncology
2024;
15
(2)
:805-806
.
(30 April 2024)
